Infusion Pump Global MedCore

Chronic Total Occlusion (CTO) Device Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Re-entry and Recanalization Devices

  • Year: 2024
  • Scope: 10 Years
  • Region: Global
  • Published Date: 2023/11/06
  • Type: MedCore

Product Description

Overall, the global chronic total occlusion (CTO) device market was valued at $225 million in 2023. This is expected to increase over the forecast period at a CAGR of 2.2% to reach $262 million.

Throughout this medical market research, we analyzed over 10 CTO companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for CTO devices extends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2030, and Historical Data to 2020
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Global CTO Device Market Insights

global CTO device market

A growing pattern in the market for CTO devices involves a heightened focus on advanced guidewire and microcatheter technologies. These technologies aim to improve the ability to navigate and cross challenging lesions successfully. These advancements are contributing to higher success rates in medical procedures and lowering the risk for patients.

Global CTO Device Market Share Insights

global CTO device market

  • In the past five years, Medtronic‘s role in the CTO device sector has transformed significantly. Initially marketing the Pioneer Plus® re-entry catheter range, Medtronic shifted focus after its acquisition by Volcano Corporation in August 2013. With the subsequent acquisition of Covidien in January 2015, Medtronic is currently promoting the Enteer™ Re-entry System and the Viance™ Crossing Catheter in the CTO device market.
  • Cardinal Health strategically claimed the top spot in the European CTO market in 2015 through the acquisition of Johnson & Johnson’s Cordis business. With approximately half of the market share, they excel by bundling CTO products with other endovascular offerings.
  • Becton Dickinson made significant moves in the CTO device market by acquiring FlowCardia in 2012. With FDA approval in 2007 and a 2011 indication for atherectomy procedures, the company distinguished its product. This strategic move positioned Becton Dickinson as a notable player, especially in a market where physicians lack reimbursements for CTO device usage.

Market Segmentation Summary

  • Re-Entry Device Market
  • Recanalization Device Market

Global Research Scope Summary

Report Attribute Details
Regions North America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year 2023
Forecast 2024-2030
Historical Data 2020-2023
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

 

FREE Sample Report

Chronic Total Occlusion Device Market
11.1 Executive Summary
11.1.1 Global Chronic Total Occlusion Device Market Overview
11.1.2 Competitive Analysis
11.1.3 Procedures Included
11.1.4 Markets Included
11.1.5 Regions Included
11.2 Introduction
11.3 Procedure Numbers
11.3.1 Total CTO Procedures
11.3.2 Re-Entry Procedures
11.3.3 Recanalization Procedures
11.4 Market Overview
11.4.1 By Segment
11.4.2 By Region
11.5 Market Analysis and Forecast
11.5.1 Total Chronic Total Occlusion Device Market
11.5.2 Re-Entry Device Market
11.5.3 Recanalization Device Market
11.6 Drivers and Limiters
11.6.1 Market Drivers
11.6.2 Market Limiters
11.7 Competitive Market Share Analysis
Medtronic
Cardinal Health
Becton Dickinson
Philips
Avinger
Boston Scientific
Others
Chart 11‑1: CTO Device Market, Global, 2023 & 2030
Chart 11‑2: CTO Procedures, Global, 2023
Chart 11‑3: CTO Procedures by Region, Global, 2020 – 2030
Chart 11‑4: CTO Device Market by Segment, Global, 2020 – 2030
Chart 11‑5: CTO Device Market by Region, Global, 2020 – 2030
Chart 11‑6: Leading Competitors, CTO Device Market, Global, 2023
Figure 11‑1: CTO Device Procedures Covered
Figure 11‑2: CTO Device Markets Covered
Figure 11‑3: CTO Device Regions Covered, Global (1 of 2)
Figure 11‑4: CTO Device Regions Covered, Global (2 of 2)
Figure 11‑5: CTO Procedures by Segment, Global, 2020 – 2030
Figure 11‑6: CTO Procedures by Region, Global, 2020 – 2030
Figure 11‑7: CTO Procedures by Country, North America, 2020 – 2030
Figure 11‑8: CTO Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 11‑9: CTO Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 11‑10: CTO Procedures by Country, Western Europe, 2020 – 2030
Figure 11‑11: CTO Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 11‑12: CTO Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 11‑13: CTO Procedures by Country, Middle East, 2020 – 2030
Figure 11‑14: CTO Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 11‑15: CTO Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 11‑16: CTO Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 11‑17: CTO Procedures by Country, Africa, 2020 – 2030
Figure 11‑18: Re-Entry Procedures by Region, Global, 2020 – 2030
Figure 11‑19: Re-Entry Procedures by Country, North America, 2020 – 2030
Figure 11‑20: Re-Entry Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 11‑21: Re-Entry Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 11‑22: Re-Entry Procedures by Country, Western Europe, 2020 – 2030
Figure 11‑23: Re-Entry Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 11‑24: Re-Entry Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 11‑25: Re-Entry Procedures by Country, Middle East, 2020 – 2030
Figure 11‑26: Re-Entry Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 11‑27: Re-Entry Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 11‑28: Re-Entry Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 11‑29: Re-Entry Procedures by Country, Africa, 2020 – 2030
Figure 11‑30: Recanalization Procedures by Region, Global, 2020 – 2030
Figure 11‑31: Recanalization Procedures by Country, North America, 2020 – 2030
Figure 11‑32: Recanalization Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 11‑33: Recanalization Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 11‑34: Recanalization Procedures by Country, Western Europe, 2020 – 2030
Figure 11‑35: Recanalization Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 11‑36: Recanalization Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 11‑37: Recanalization Procedures by Country, Middle East, 2020 – 2030
Figure 11‑38: Recanalization Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 11‑39: Recanalization Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 11‑40: Recanalization Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 11‑41: Recanalization Procedures by Country, Africa, 2020 – 2030
Figure 11‑42: CTO Device Market by Segment, Global, 2020 – 2030 (US$M)
Figure 11‑43: CTO Device Market by Region, Global, 2020 – 2030 (US$M)
Figure 11‑44: Total CTO Device Market, Global, 2020 – 2030
Figure 11‑45: Units Sold by Region, CTO Device Market, Global, 2020 – 2030
Figure 11‑46: Average Selling Price by Region, CTO Device Market, Global, 2020 – 2030 (US$)
Figure 11‑47: Market Value by Region, CTO Device Market, Global, 2020 – 2030 (US$M)
Figure 11‑48: Re-Entry Device Market, Global, 2020 – 2030
Figure 11‑49: Units Sold by Region, Re-Entry Device Market, Global, 2020 – 2030
Figure 11‑50: Average Selling Price by Region, Re-Entry Device Market, Global, 2020 – 2030 (US$)
Figure 11‑51: Market Value by Region, Re-Entry Device Market, Global, 2020 – 2030 (US$M)
Figure 11‑52: Recanalization Device Market, Global, 2020 – 2030
Figure 11‑53: Units Sold by Region, Recanalization Device Market, Global, 2020 – 2030
Figure 11‑54: Average Selling Price by Region, Recanalization Device Market, Global, 2020 – 2030 (US$)
Figure 11‑55: Market Value by Region, Recanalization Device Market, Global, 2020 – 2030 (US$M)
Figure 11‑56: Leading Competitors, CTO Device Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

Overall, the global chronic total occlusion (CTO) device market was valued at $225 million in 2023. This is expected to increase over the forecast period at a CAGR of 2.2% to reach $262 million.

  • 2024
  • 10 Years
  • Global
  • MedCore
  • 2023/11/06
SKU: iDATA_GLPV24_MC_CTO Categories: , , , , , , , , , , , ,
Request Sample Sheets Request Customization
Related Reports
+

REQUEST SAMPLE SHEETS

+

REQUEST CUSTOMIZATION

+

Free Sample Report Form

+

See Report Summary

0
    0
    Your Cart
    Your cart is emptyReturn to Report Library